Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Stem Cell Transplantation
Interventions: Biological: Auto-hMSCs; Biological: Allo-hMSCs
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); University of Miami
Not yet recruiting - verified October 2009
Conditions: Cardiovascular Disease; Obstructive Sleep Apnea; Coronary Artery Disease
Interventions: Other: Healthy Lifestyles and Sleep Education plus PAP; Other: Healthy Lifestyles and Sleep Education plus Supplemental Oxygen; Other: Healthy Lifestyles and Sleep Education
Sponsors: University Hospitals of Cleveland; Case Western Reserve University; Partners HealthCare; Johns Hopkins University; VA Boston Healthcare System
Recruiting - verified March 2010
Condition: Coronary Artery Disease
Intervention: Drug: Omacor, omega-3 fatty acids in CAD patients
Sponsors: HeartDrug Research LLC; University of Oslo
Not yet recruiting - verified March 2010
Condition: Pregnant Women With Peripartum Cardiomyopathy
Intervention:
Sponsors: University of Pittsburgh; National Institutes of Health (NIH)
Recruiting - verified March 2010
Condition: Epilepsy
Intervention:
Sponsors: The Epilepsy Study Consortium; Eisai Inc.; GlaxoSmithKline; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; H. Lundbeck A/S; Pfizer; Supernus Pharmaceuticals, Inc.; UCB, Inc.
Enrolling by invitation - verified March 2010
Condition: Prostate Cancer
Interventions: Drug: Testosterone; Drug: Etoposide
Sponsor: Sidney Kimmel Comprehensive Cancer Center
Recruiting - verified March 2010
Condition: Down Syndrome
Interventions: Drug: Rivastigmine; Other: Liquid Placebo
Sponsors: Duke University; Taishoff Family Foundation
Recruiting - verified March 2010
Conditions: Peanut Hypersensitivity; Food Hypersensitivity; Immediate Hypersensitivity
Interventions: Drug: Peanut powder; Drug: Peanut extract; Drug: Placebo extract; Drug: Placebo powder
Sponsor: Johns Hopkins University
Recruiting - verified March 2010
Conditions: Autism; Asperger's Disorder; Pervasive Developmental Disorder NOS
Interventions: Drug: memantine; Drug: Placebo
Sponsors: Johns Hopkins University; Forest Laboratories
Enrolling by invitation - verified March 2010
Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); National Institute on Aging (NIA); National Institutes of Health (NIH)
Not yet recruiting - verified March 2010
Condition: Metastatic Pancreatic Cancer
Intervention: Drug: Gemcitabine, nab-Paclitaxel, GDC-0449
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Stand Up To Cancer; Genentech; Abraxis BioScience Inc.
Not yet recruiting - verified March 2010
Condition: Pancreatic Cancer
Intervention: Biological: PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.
Sponsor: Sidney Kimmel Comprehensive Cancer Center
Not yet recruiting - verified March 2010
Condition: Diabetic Macular Edema
Interventions: Drug: Ranibizumab; Drug: ranibizumab
Sponsors: Johns Hopkins University; Juvenile Diabetes Research Foundation
Recruiting - verified February 2010
Conditions: Ischemic Cardiomyopathy; Nonischemic Cardiomyopathy
Intervention:
Sponsors: Johns Hopkins University; Donald W. Reynolds Foundation; Christiana Care Health Services
Recruiting - verified February 2010
Condition: Malignant Ascites
Interventions: Procedure: paracentesis; Device: pleurx catheter
Sponsor: Sidney Kimmel Comprehensive Cancer Center
Recruiting - verified February 2010
Condition: Breast Cancer
Interventions: Drug: Hedgehog antagonist GDC-0449; Drug: gamma-secretase inhibitor RO4929097; Other: laboratory biomarker analysis; Other: pharmacogenomic studies; Other: pharmacological study
Sponsors: Barbara Ann Karmanos Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified February 2010